Avidity Biosciences Inc
RNAM
Rank in Stocks
#2081
Avidity Biosciences, Inc. is at the forefront of developing a novel class of... Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.
Share Price
$71.34
Last synced: 2026-03-03
Market Cap
$9.84B
Change (1 day)
0.00%
Change (1 year)
-
Country
US
Trade Avidity Biosciences Inc (RNAM)
Category
Healthcare
Stock price history for Avidity Biosciences Inc (RNAM)
Highest end of day price: $71.34 on 2026-03-01
Lowest end of day price: $72.56 on 2026-01-01
Lowest end of day price: $72.56 on 2026-01-01
Stock price history of Avidity Biosciences Inc from 2026 to 2026
Annual Stock Price Performance
| Year | Performance | |
|---|---|---|
| Not enough data for the provided dates. | ||
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $764.76 | 8.70% |
CH
|
